...
首页> 外文期刊>JMIR diabetes. >Impact of New Technologies for Middle-Aged and Older Patients: In-Depth Interviews With Type 2 Diabetes Patients Using Continuous Glucose Monitoring
【24h】

Impact of New Technologies for Middle-Aged and Older Patients: In-Depth Interviews With Type 2 Diabetes Patients Using Continuous Glucose Monitoring

机译:新技术对中老年患者的影响:使用连续血糖监测对2型糖尿病患者进行深度访谈

获取原文
           

摘要

Background: Continuous glucose monitoring (CGM) uses subcutaneous sensors and records the average interstitial sensor current every 5 min in the recorder; data are subsequently exported to a computer 4 to 7 days later when calibration with self-measured blood glucose is made retrospectively. How middle-aged and older patients perceive the added technology intervention is not clear. Objective: The study aimed to understand the factors associated with the adoption of new technology in diabetes care, to understand the feelings and behaviors while using it, and to determine the changes in attitudes and behavior after completing the use of the new technology at the 3-month follow-up. Methods: Middle-aged and older type 2 diabetes patients who had received professional continuous glucose monitoring (iPro 2 [Medtronic]) were invited for semistructured in-depth interviews on the day of the CGM sensor removal and at 3 months after CGM-based counseling. A phenomenography approach was used to analyze the interview data. Results: A total of 20 type 2 diabetes patients (aged 53 to 72 years, 13 males and 7 females, 4 to 40 years duration of diabetes, mean glycated hemoglobin 8.54% [SD 0.71%]) completed 2 sections of semistructured in-depth interviews. Physician guidance and participant motivation toward problem solving were found to be factors associated with adoption of the device. Participants indicated that technology can be a reminder, a supervisor, and a visualizer of blood glucose, all of which are helpful for disease management. However, CGM is somewhat inconvenient, and some participants also reported that the provision of this new technology might be a hint of disease progression. There was a higher percentage of women compared with men who reported that CGM can be a reminder or a supervisor to help them with diet control. Conclusions: Physician guidance and participants’ degree of motivation are keys to adopting new technology in the case of middle-aged and older adults. Although the CGM sensor may cause inconvenience to patients on their limited body movement when wearing the device, it is helpful for diet control and is an effective behavioral modification tool that offers support, especially in the case of women.
机译:背景:连续葡萄糖监测(CGM)使用皮下传感器,每5分钟在记录仪中记录一次平均间质传感器电流。当回顾性地使用自测血糖进行校准时,数据随后会在4至7天后输出到计算机。目前尚不清楚中老年人如何看待增加的技术干预。目的:本研究旨在了解在糖尿病护理中采用新技术的相关因素,了解在使用新技术时的感受和行为,并确定在3岁时完成新技术使用后的态度和行为变化。个月的随访。方法:在CGM传感器拆除当天和基于CGM的咨询后3个月,邀请接受专业连续血糖监测(iPro 2 [Medtronic])的中老年2型糖尿病患者进行半结构化深度访谈。 。现象学方法用于分析采访数据。结果:共有20例2型糖尿病患者(年龄53至72岁,男性13例,女性7例,糖尿病病程4到40年,平均糖化血红蛋白8.54%[SD 0.71%])完成了2处半结构性深层切除术面试发现医师的指导和参与者解决问题的动机是与采用设备相关的因素。与会者指出,技术可以成为血糖的提醒,监控和可视化工具,所有这些技术都有助于疾病管理。但是,CGM有点不方便,一些参与者还报告说,提供这项新技术可能暗示疾病进展。与男性相比,女性比例更高,因为男性认为CGM可以提醒或指导他们控制饮食。结论:在中老年人中,医师的指导和参与者的积极性是采用新技术的关键。尽管CGM传感器在佩戴该设备时可能会限制患者的身体动作,但会给患者带来不便,但它有助于饮食控制,是一种有效的行为调节工具,可提供支持,尤其是在女性的情况下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号